Dr. Vitiello's Journey
PersImmune, Inc. was founded in 2010 with the mission of developing precision cancer immunotherapy tailored to each patient. The company’s founding officer is Dr. Antonella Vitiello (Chief Executive Officer and Chief Scientific Officer). Dr. Vitiello’s career as a ground-breaking cancer researcher and her own successful fight against cancer drive the company’s passion for developing safe and effective cancer therapies that preserve the patient’s quality of life and avoid the devastating side effects of currently available cancer treatments.